Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis

被引：16

作者：

Donald, Michael B. ^{[3
]}

Rodriguez, Kevin X. ^{[3
]}

Shay, Hannah ^{[3
]}

Phuan, Puay-Wah ^{[1
,2
]}

Verkman, A. S. ^{[1
,2
]}

Kurth, Mark J. ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA

[3] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2012年 / 20卷 / 17期

基金：

美国国家卫生研究院; 美国国家科学基金会;

关键词：

CuAAC; Triazolobithiazole; Cystic fibrosis; CF corrector; TRANSMEMBRANE CONDUCTANCE REGULATOR;

D O I：

10.1016/j.bmc.2012.06.046

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Copper catalyzed azide-alkyne cycloaddition (CuAAC) chemistry is reported for the construction of previously unknown 5-(1H-1,2,3-triazol-1-yl)-4,5'-bithiazoles from 2-bromo-1-(thiazol-5-yl)ethanones. These novel triazolobithiazoles are shown to have cystic fibrosis (CF) corrector activity and, compared to the benchmark bithiazole CF corrector corr-4a, improved log P values (4.5 vs 5.96). (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：5247 / 5253

页数：7

共 12 条

[1] Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening [J].

Bobadilla, JL ;

Macek, M ;

Fine, JP ;

Farrell, PM .

HUMAN MUTATION, 2002, 19 (06) :575-606

[2] 'Click' cycloaddition catalysts: copper(I) and copper(II) tris(triazolylmethyl)amine complexes [J].

Donnelly, Paul S. ;

Zanatta, Shannon D. ;

Zammit, Steven C. ;

White, Jonathan M. ;

Williams, Spencer J. .

CHEMICAL COMMUNICATIONS, 2008, (21) :2459-2461

[3] A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases [J].

Ghose, AK ;

Viswanadhan, VN ;

Wendoloski, JJ .

JOURNAL OF COMBINATORIAL CHEMISTRY, 1999, 1 (01) :55-68

[4]

Hantzsch A., 1889, JUSTUS LIEBIGS ANN C, V250, P257

[5]

Katritzky A. R., 1993, ACTA CHEM SCAND, P167

[6] Synthesis, spectral description, and lipophilicity parameters determination of phenylcarbamic acid derivatives with integrated N-phenylpiperazine moiety in the structure [J].

Malík, I ;

Sedlárová, E ;

Csöllei, J ;

Andriamainty, F ;

Kurfürst, P ;

Vanco, J .

CHEMICAL PAPERS-CHEMICKE ZVESTI, 2006, 60 (01) :42-47

[7] Conformational and temperature-sensitive stability defects of the ΔF508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments [J].

Sharma, M ;

Benharouga, M ;

Hu, W ;

Lukacs, GL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) :8942-8950

[8] 2-anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: Synthesis, SAR analysis, X-ray crystallography, and biological activity [J].

Wang, SD ;

Meades, C ;

Wood, G ;

Osnowski, A ;

Anderson, S ;

Yuill, R ;

Thomas, M ;

Mezna, M ;

Jackson, W ;

Midgley, C ;

Griffiths, G ;

Fleming, I ;

Green, S ;

McNae, I ;

Wu, SY ;

McInnes, C ;

Zheleva, D ;

Walkinshaw, MD ;

Fischer, PM .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1662-1675

[9] Nanomolar affinity small molecule correctors of defective ΔF508-CFTR chloride channel gating [J].

Yang, H ;

Shelat, AA ;

Guy, RK ;

Gopinath, VS ;

Ma, TH ;

Du, K ;

Lukacs, GL ;

Taddei, A ;

Folli, C ;

Pedemonte, N ;

Galietta, LJV ;

Verkman, AS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35079-35085

[10] Pyrazolylthiazole as ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator Correctors with Improved Hydrophilicity Compared to Bithiazoles [J].

Ye, Long ;

Knapp, John M. ;

Sangwung, Panjamaporn ;

Fettinger, James C. ;

Verkman, A. S. ;

Kurth, Mark J. .

JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (09) :3772-3781

← 1 2 →